ESTABLISHMENT LABS HOLDINGS (ESTA)
VGG312491084 - Common Stock
ESTA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 195 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ESTA have multiple concerns. ESTA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ESTA had negative earnings in the past year.
ESTA had a negative operating cash flow in the past year.
In the past 5 years ESTA always reported negative net income.
In the past 5 years ESTA always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -29.22%, ESTA is in line with its industry, outperforming 46.15% of the companies in the same industry.
With a Return On Equity value of -426.76%, ESTA is not doing good in the industry: 87.18% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.22% | ||
| ROE | -426.76% | ||
| ROIC | N/A |
ROA(3y)-31.44%
ROA(5y)-30.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ESTA has a better Gross Margin (64.77%) than 67.69% of its industry peers.
ESTA's Gross Margin has improved in the last couple of years.
ESTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.48%
GM growth 5Y1.89%
2. Health
2.1 Basic Checks
ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ESTA has more shares outstanding
ESTA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ESTA has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.69, we must say that ESTA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ESTA (1.69) is comparable to the rest of the industry.
A Debt/Equity ratio of 10.26 is on the high side and indicates that ESTA has dependencies on debt financing.
ESTA has a Debt to Equity ratio of 10.26. This is amonst the worse of the industry: ESTA underperforms 90.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.69 |
ROIC/WACCN/A
WACC9.66%
2.3 Liquidity
ESTA has a Current Ratio of 3.06. This indicates that ESTA is financially healthy and has no problem in meeting its short term obligations.
ESTA's Current ratio of 3.06 is in line compared to the rest of the industry. ESTA outperforms 48.72% of its industry peers.
ESTA has a Quick Ratio of 1.67. This is a normal value and indicates that ESTA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.67, ESTA is doing worse than 65.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.06 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.98% over the past year.
Looking at the last year, ESTA shows a small growth in Revenue. The Revenue has grown by 2.13% in the last year.
The Revenue has been growing by 21.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)0.98%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-43.64%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y24.93%
Revenue growth 5Y21.96%
Revenue growth Q2Q-27.96%
3.2 Future
The Earnings Per Share is expected to grow by 24.49% on average over the next years. This is a very strong growth
Based on estimates for the next years, ESTA will show a very strong growth in Revenue. The Revenue will grow by 28.14% on average per year.
EPS Next Y42.73%
EPS Next 2Y33.76%
EPS Next 3Y30.03%
EPS Next 5Y24.49%
Revenue Next Year9.43%
Revenue Next 2Y22.35%
Revenue Next 3Y25.3%
Revenue Next 5Y28.14%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ESTA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ESTA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ESTA's earnings are expected to grow with 30.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.76%
EPS Next 3Y30.03%
5. Dividend
5.1 Amount
No dividends for ESTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ESTABLISHMENT LABS HOLDINGS
NASDAQ:ESTA (4/25/2024, 7:00:01 PM)
After market: 48.54 0 (0%)48.54
-0.41 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.33B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.22% | ||
| ROE | -426.76% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.77% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.26 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.06 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)0.98%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y42.73%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.13%
Revenue growth 3Y24.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y